RxDoctor Payments Data

Rick Roberts, MD

Family Medicine · Nampa, IDNPI 1558351551

Payments from drug & device makers

$654in general payments, 2019–2025

Across 31 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$99
  • Sanofi$90
  • Pfizer$83
  • Novo Nordisk$75
  • AbbVie$56
  • AstraZeneca$54
  • plus $197 from 9 others

What the payments were for

  • Speaking & faculty fees$9014%
  • Food & beverage$56486%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$654 in reported general payments places this provider in the 65th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$105,732
Medicare patients
245
Services billed
1,662

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban136$122,592
OzempicSemaglutide67$81,393
JardianceEmpagliflozin47$61,737
TrulicityDulaglutide35$43,572
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen768$31,866
JanuviaSitagliptin Phosphate32$27,455
FarxigaDapagliflozin Propanediol16$23,565
Oxymorphone Hcl ErOxymorphone Hcl13$21,256
MounjaroTirzepatide17$18,177
JanumetSitagliptin Phos/Metformin Hcl12$16,907
OxycontinOxycodone Hcl26$16,290
TradjentaLinagliptin12$13,418
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$12,487
Spiriva HandihalerTiotropium Bromide13$12,155
Morphine Sulfate ErMorphine Sulfate253$11,940

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$83$128,735150 claims
Novo NordiskOzempic$75$81,39367 claims
Boehringer IngelheimJardiance, Tradjenta$99$75,15559 claims
Lilly USA, LLCTrulicity, Mounjaro$19$61,74952 claims
MerckJanuvia, Janumet$15$44,36244 claims
AstraZenecaFarxiga, Symbicort$54$26,35828 claims
GSKTrelegy Ellipta$18$10,50212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 803 family medicine providers in Idaho.

Other family medicine in Nampa

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →